Literature DB >> 29987812

Induction of Human Induced Pluripotent Stem Cells to Cardiomyocytes Using Embryoid Bodies.

Takeshi Hatani1,2, Kenji Miki2, Yoshinori Yoshida3.   

Abstract

Specific cell lineages differentiated from human induced pluripotent stem cells (iPSCs) are promising sources for cell replacement therapy and are useful biomedical research tools for research on disease mechanisms and drug discovery. Among the different lineages, cardiac lineage has been one of the most efficiently differentiated through several established protocols. In this chapter, we describe our reproducible and highly efficient methodology for differentiating iPSCs into cardiomyocytes using embryoid bodies. We also describe methods to dissociate iPSC-derived cardiomyocytes and to evaluate iPSC-derived cardiomyocytes.

Entities:  

Keywords:  Cardiac differentiation; Cardiomyocyte; Embryoid body; Human induced pluripotent stem cells; Reaggregation

Mesh:

Year:  2018        PMID: 29987812     DOI: 10.1007/978-1-4939-8597-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  10 in total

1.  Purification of human iPSC-derived cells at large scale using microRNA switch and magnetic-activated cell sorting.

Authors:  Yuta Tsujisaka; Takeshi Hatani; Chikako Okubo; Ryo Ito; Azuma Kimura; Megumi Narita; Kazuhisa Chonabayashi; Shunsuke Funakoshi; Antonio Lucena-Cacace; Taro Toyoda; Kenji Osafune; Takeshi Kimura; Hirohide Saito; Yoshinori Yoshida
Journal:  Stem Cell Reports       Date:  2022-06-09       Impact factor: 7.294

Review 2.  Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells.

Authors:  Jiangtao Li; Xin Feng; Xiang Wei
Journal:  Stem Cell Res Ther       Date:  2022-06-03       Impact factor: 8.079

3.  Transplantation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Mouse Myocardial Infarction Model.

Authors:  Takeshi Hatani; Yoshinori Yoshida
Journal:  Methods Mol Biol       Date:  2021

4.  Nano-structural analysis of engrafted human induced pluripotent stem cell-derived cardiomyocytes in mouse hearts using a genetic-probe APEX2.

Authors:  Takeshi Hatani; Shunsuke Funakoshi; Thomas J Deerinck; Eric A Bushong; Takeshi Kimura; Hiroshi Takeshima; Mark H Ellisman; Masahiko Hoshijima; Yoshinori Yoshida
Journal:  Biochem Biophys Res Commun       Date:  2018-10-15       Impact factor: 3.575

5.  Noonan syndrome patient-specific induced cardiomyocyte model carrying SOS1 gene variant c.1654A>G.

Authors:  Narasimman Gurusamy; Sheeja Rajasingh; Vinoth Sigamani; Reshma Rajasingh; Dona Greta Isai; Andras Czirok; Douglas Bittel; Johnson Rajasingh
Journal:  Exp Cell Res       Date:  2021-02-04       Impact factor: 3.905

Review 6.  Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.

Authors:  Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

7.  A versatile and robust cell purification system with an RNA-only circuit composed of microRNA-responsive ON and OFF switches.

Authors:  Yoshihiko Fujita; Moe Hirosawa; Karin Hayashi; Takeshi Hatani; Yoshinori Yoshida; Takuya Yamamoto; Hirohide Saito
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

Review 8.  Multicellular 3D Models for the Study of Cardiac Fibrosis.

Authors:  Vittorio Picchio; Erica Floris; Yuriy Derevyanchuk; Claudia Cozzolino; Elisa Messina; Francesca Pagano; Isotta Chimenti; Roberto Gaetani
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

Review 9.  A Concise Review on Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Personalized Regenerative Medicine.

Authors:  Pallavi Pushp; Diogo E S Nogueira; Carlos A V Rodrigues; Frederico C Ferreira; Joaquim M S Cabral; Mukesh Kumar Gupta
Journal:  Stem Cell Rev Rep       Date:  2020-10-23       Impact factor: 5.739

Review 10.  Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective.

Authors:  Mohamed M Bekhite; P Christian Schulze
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.